C4 Therapeutics (CCCC)

C4 Therapeutics (CCCC) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• CCCC last traded at $3.37, 2.12% on the day.
• C4 Therapeutics: P/E -3.3, revenue $35.04M over the last four quarters.
• Over the past year CCCC returned 36.99%; year to date 76.44%.

Updated 2026-11-02 17:48 UTC